Gut Microbiota, the Potential Biological Medicine for Prevention, Intervention and Drug Sensitization to Fight Diseases

Overview

Journal Nutrients

Date 2022 Oct 27

PMID 36296908

Authors

Haijie Wu

Xiaoguang Chen

Sen Zhang

Jiaxin Li

Affiliations

Soon will be listed here.

Abstract

As the largest "immune organ" of human beings, the gut microbiota is symbiotic and mutually beneficial with the human host, playing multiple physiological functions. Studies have long shown that dysbiosis of gut microbiota is associated with almost all human diseases, mainly including type II diabetes, cancers, neurodegenerative diseases, autism spectrum disorder, and kidney diseases. As a novel and potential biological medicine for disease prevention, intervention and drug sensitization, the gut microbiota has attracted more and more attention recently. Although the gut microbiota is a comprehensive microbial community, several star bacteria have emerged as possible tools to fight against various diseases. This review aims to elucidate the relevance of gut microbiota dysbiosis with disease occurrence and progression, and mainly summarizes four well-known genera with therapeutic and sensitizing potential, , , and , thoroughly elucidate their potential value as biological drugs to treat diverse disease.

Citing Articles

A two-sample Mendelian randomization study reveals the causal effects of statin medication on gut microbiota abundance in the European population.

Zhou P, Qiu C, Zhuang Z, Shi K, Yang Z, Ding Y Front Genet. 2024; 15:1380830.

PMID: 39734574 PMC: 11674602. DOI: 10.3389/fgene.2024.1380830.

Causal associations between gut microbiota and cutaneous melanoma: a Mendelian randomization study.

Bao Y, Zhang Y, Li Z Front Microbiol. 2024; 15:1339621.

PMID: 38650882 PMC: 11033470. DOI: 10.3389/fmicb.2024.1339621.

Evaluation of Bacterial and Fungal Biomarkers for Differentiation and Prognosis of Patients with Inflammatory Bowel Disease.

Yoon H, Park S, Jun Y, Choi Y, Shin C, Park Y Microorganisms. 2023; 11(12).

PMID: 38138026 PMC: 10745905. DOI: 10.3390/microorganisms11122882.

Melatonin: Both a Messenger of Darkness and a Participant in the Cellular Actions of Non-Visible Solar Radiation of Near Infrared Light.

Tan D, Reiter R, Zimmerman S, Hardeland R Biology (Basel). 2023; 12(1).

PMID: 36671781 PMC: 9855654. DOI: 10.3390/biology12010089.

References

Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L . A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2016; 23(1):107-113. DOI: 10.1038/nm.4236. View

Bullingham R, Nicholls A, Kamm B . Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet. 1998; 34(6):429-55. DOI: 10.2165/00003088-199834060-00002. View

Sharon G, Cruz N, Kang D, Gandal M, Wang B, Kim Y . Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice. Cell. 2019; 177(6):1600-1618.e17. PMC: 6993574. DOI: 10.1016/j.cell.2019.05.004. View

Rossi M, Amaretti A, Raimondi S . Folate production by probiotic bacteria. Nutrients. 2012; 3(1):118-34. PMC: 3257725. DOI: 10.3390/nu3010118. View

Lai H, Lin T, Chen T, Kuo Y, Chang C, Wu T . Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory lipopolysaccharide. Gut. 2021; 71(2):309-321. DOI: 10.1136/gutjnl-2020-322599. View

Li X, Liu L, Cao Z, Li W, Li H, Lu C . Gut microbiota as an "invisible organ" that modulates the function of drugs. Biomed Pharmacother. 2019; 121:109653. DOI: 10.1016/j.biopha.2019.109653. View

Si W, Liang H, Bugno J, Xu Q, Ding X, Yang K . GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade. Gut. 2021; 71(3):521-533. PMC: 8710942. DOI: 10.1136/gutjnl-2020-323426. View

Taranto M, Vera J, Hugenholtz J, DE Valdez G, Sesma F . Lactobacillus reuteri CRL1098 produces cobalamin. J Bacteriol. 2003; 185(18):5643-7. PMC: 193752. DOI: 10.1128/JB.185.18.5643-5647.2003. View

Huang Y, Xin W, Xiong J, Yao M, Zhang B, Zhao J . The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease. Front Pharmacol. 2022; 13:837500. PMC: 8971625. DOI: 10.3389/fphar.2022.837500. View

10.

Rea M, Sit C, Clayton E, OConnor P, Whittal R, Zheng J . Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci U S A. 2010; 107(20):9352-7. PMC: 2889069. DOI: 10.1073/pnas.0913554107. View

11.

Gerard P . Gut microbiota and obesity. Cell Mol Life Sci. 2015; 73(1):147-62. PMC: 11108539. DOI: 10.1007/s00018-015-2061-5. View

12.

Derosa L, Routy B, Thomas A, Iebba V, Zalcman G, Friard S . Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nat Med. 2022; 28(2):315-324. PMC: 9330544. DOI: 10.1038/s41591-021-01655-5. View

13.

Cani P, de Vos W . Next-Generation Beneficial Microbes: The Case of . Front Microbiol. 2017; 8:1765. PMC: 5614963. DOI: 10.3389/fmicb.2017.01765. View

14.

Cammarota G, Ianiro G, Tilg H, Rajilic-Stojanovic M, Kump P, Satokari R . European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017; 66(4):569-580. PMC: 5529972. DOI: 10.1136/gutjnl-2016-313017. View

15.

Lai C, Lin T, Huang M, Li S, Wu H, Chiu Y . Gut Commensal MTS01 Alters Gut Microbiota Composition and Reduces Cholesterol to Mitigate -Induced Pathogenesis. Front Immunol. 2022; 13:916848. PMC: 9281563. DOI: 10.3389/fimmu.2022.916848. View

16.

Kim D . Gut microbiota-mediated pharmacokinetics of ginseng saponins. J Ginseng Res. 2018; 42(3):255-263. PMC: 6026358. DOI: 10.1016/j.jgr.2017.04.011. View

17.

Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S . Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019; 25(7):1096-1103. PMC: 6699990. DOI: 10.1038/s41591-019-0495-2. View

18.

Li W, Deng Y, Chu Q, Zhang P . Gut microbiome and cancer immunotherapy. Cancer Lett. 2019; 447:41-47. DOI: 10.1016/j.canlet.2019.01.015. View

19.

Ma Q, Li Y, Li P, Wang M, Wang J, Tang Z . Research progress in the relationship between type 2 diabetes mellitus and intestinal flora. Biomed Pharmacother. 2019; 117:109138. DOI: 10.1016/j.biopha.2019.109138. View

20.

Yao S, Zhao Z, Wang W, Liu X . Bifidobacterium Longum: Protection against Inflammatory Bowel Disease. J Immunol Res. 2021; 2021:8030297. PMC: 8324359. DOI: 10.1155/2021/8030297. View